Back to results
US 8,569,255 B2Granted
Post-exposure therapy of influenza A infections
AssigneeHer Majesty the Queen in right of Canada, as represented by the Minister of National Defence
InventorJonathan P. Wong
Life of this patent
Estimating the term…
Abstract
Poly ICLC or liposome-encapsulated Poly ICLC (LE Poly ICLC) in combination with antisense oligonucleotides (AS) act synergistically in post-exposure prophylaxis or therapy of influenza infections, especially H5N1 virus infections.
Claims13
A method of treating an influenza virus infection in a subject consisting essentially of administering to the subject, after the subject has been exposed to the influenza virus, a synergistic combination of
- Poly ICLC or liposome-encapsulated Poly ICLC (LE Poly ICLC), and
- an antisense oligonucleotide comprising the nucleotide sequence as set forth in SEQ ID NO:
- 4.
Dependencies are inferred from the claim text.